BlackRock Health Sciences Trust (NYSE:BME) Short Interest Update

BlackRock Health Sciences Trust (NYSE:BMEGet Rating) was the recipient of a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 95,400 shares, a growth of 36.3% from the June 30th total of 70,000 shares. Based on an average trading volume of 42,000 shares, the days-to-cover ratio is currently 2.3 days.

BlackRock Health Sciences Trust Trading Up 0.9 %

Shares of BME stock opened at $43.82 on Monday. The company has a 50 day moving average price of $42.65 and a 200-day moving average price of $43.53. BlackRock Health Sciences Trust has a 52 week low of $39.51 and a 52 week high of $49.76.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently disclosed a monthly dividend, which was paid on Friday, July 29th. Investors of record on Friday, July 15th were issued a $0.213 dividend. This represents a $2.56 dividend on an annualized basis and a dividend yield of 5.83%. The ex-dividend date of this dividend was Thursday, July 14th.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Huntington National Bank purchased a new position in shares of BlackRock Health Sciences Trust in the first quarter worth approximately $36,000. Janney Montgomery Scott LLC lifted its holdings in BlackRock Health Sciences Trust by 5.5% during the first quarter. Janney Montgomery Scott LLC now owns 22,744 shares of the company’s stock valued at $1,035,000 after purchasing an additional 1,190 shares in the last quarter. Raymond James & Associates lifted its holdings in BlackRock Health Sciences Trust by 3.4% during the first quarter. Raymond James & Associates now owns 36,540 shares of the company’s stock valued at $1,663,000 after purchasing an additional 1,207 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its holdings in BlackRock Health Sciences Trust by 7.6% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 21,579 shares of the company’s stock valued at $1,047,000 after purchasing an additional 1,524 shares in the last quarter. Finally, UMB Bank N A MO purchased a new position in BlackRock Health Sciences Trust during the fourth quarter valued at approximately $76,000.

About BlackRock Health Sciences Trust

(Get Rating)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Read More

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.